Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Opinion   Independent Reports   Zacks Small-Cap Research initiates coverage of...

Zacks Small-Cap Research initiates coverage of Medicus Pharma (TSXV:MDCX)

Research Research, The Market Online
0 Comments| January 10, 2024
{{labelSign}}  Favorites
{{errorMessage}}
Click to enlarge

Click here to download the report.

This is third-party provided content issued on behalf of Medicus Pharma Ltd. (TSXV:MDCX), please see full disclaimer here.

Join the discussion: Find out what everybody’s saying about this stock on the Medicus Pharma Ltd. Bullboard investor discussion forum, and check out the rest of Stockhouse’s stock forums and message boards.


Tags:
HEALTHCARE
{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company

Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc. C.AGN

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed ... view more »